current as T Cells + the Induction of Profibrotic CD 8 IL-21 Promotes Pulmonary Fibrosis through

[1]  M. Nussenzweig,et al.  Dynamic signaling by T follicular helper cells during germinal center B cell selection , 2014, Science.

[2]  C. King,et al.  IL-21–Producing Th Cells in Immunity and Autoimmunity , 2013, The Journal of Immunology.

[3]  W. Leonard,et al.  IL-21 Restricts Virus-driven Treg Cell Expansion in Chronic LCMV Infection , 2013, PLoS pathogens.

[4]  E. R. Sutherland,et al.  IL‐13‐producing BLT1‐positive CD8 cells are increased in asthma and are associated with airway obstruction , 2013, Allergy.

[5]  Bettina Zelger,et al.  The immunology of fibrosis. , 2013, Annual review of immunology.

[6]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[7]  M. V. von Herrath,et al.  Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. , 2012, Immunity.

[8]  M. Kopf,et al.  IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. , 2012, Blood.

[9]  A. Rudensky,et al.  Regulatory T cells: mechanisms of differentiation and function. , 2012, Annual review of immunology.

[10]  W. Leonard,et al.  IL-21 Promotes the Pathologic Immune Response to Pneumovirus Infection , 2012, The Journal of Immunology.

[11]  W. Leonard,et al.  IL-21 Is an Antitolerogenic Cytokine of the Late-Phase Alloimmune Response , 2011, Diabetes.

[12]  S. Forbes,et al.  Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. , 2011, American journal of respiratory and critical care medicine.

[13]  G. Melino,et al.  Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice , 2011, The Journal of experimental medicine.

[14]  Thomas A. Wynn,et al.  Integrating mechanisms of pulmonary fibrosis , 2011, The Journal of experimental medicine.

[15]  W. Luttmann,et al.  Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. , 2010, Clinical immunology.

[16]  T. Wynn,et al.  Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent , 2010, The Journal of experimental medicine.

[17]  T. Standiford,et al.  Therapeutic Efficacy of Cintredekin Besudotox (IL13-PE38QQR) in Murine Lung Fibrosis Is Unaffected by Immunity to Pseudomonas aeruginosa Exotoxin A , 2010, PloS one.

[18]  C. Drake,et al.  STAT3 Signaling in CD4+ T Cells Is Critical for the Pathogenesis of Chronic Sclerodermatous Graft-Versus-Host Disease in a Murine Model , 2009, The Journal of Immunology.

[19]  W. Leonard,et al.  New insights into the regulation of T cells by γc family cytokines , 2009, Nature Reviews Immunology.

[20]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[21]  Mohamed El-behi,et al.  IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells1 , 2009, The Journal of Immunology.

[22]  T. Medsger,et al.  Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis. , 2009, Arthritis and rheumatism.

[23]  W. Leonard,et al.  The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. , 2008, Current opinion in immunology.

[24]  S. Kleeberger,et al.  Mouse Models of Bleomycin‐Induced Pulmonary Fibrosis , 2008, Current protocols in pharmacology.

[25]  N. Todd,et al.  Roles of T lymphocytes in pulmonary fibrosis , 2008, Journal of leukocyte biology.

[26]  Lai Wei,et al.  IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent Manner* , 2007, Journal of Biological Chemistry.

[27]  Terry B. Strom,et al.  IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.

[28]  M. Kurrer,et al.  IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo. , 2007, Blood.

[29]  L. Kaer,et al.  Natural killer T cells and CD8+ T cells are dispensable for T cell–dependent allergic airway inflammation , 2006, Nature Medicine.

[30]  T. Wynn,et al.  The IL-21 receptor augments Th2 effector function and alternative macrophage activation. , 2006, The Journal of clinical investigation.

[31]  T. Macdonald,et al.  Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 , 2006, Gut.

[32]  Z. Daniil,et al.  Relationship of BAL and lung tissue CD4+ and CD8+ T lymphocytes, and their ratio in idiopathic pulmonary fibrosis. , 2005, Chest.

[33]  S. Forbes,et al.  Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. , 2005, The Journal of clinical investigation.

[34]  K. Kuwano,et al.  The perforin mediated apoptotic pathway in lung injury and fibrosis , 2004, Journal of Clinical Pathology.

[35]  L. Wakefield,et al.  IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent , 2004, The Journal of Immunology.

[36]  E. Gelfand,et al.  Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness , 2004, Nature Medicine.

[37]  E. Gelfand,et al.  Contribution of Antigen-Primed CD8+ T Cells to the Development of Airway Hyperresponsiveness and Inflammation Is Associated with IL-131 , 2004, The Journal of Immunology.

[38]  R. Puri,et al.  Therapeutic Attenuation of Pulmonary Fibrosis Via Targeting of IL-4- and IL-13-Responsive Cells 1 , 2003, The Journal of Immunology.

[39]  A. Sher,et al.  A Critical Role for IL-21 in Regulating Immunoglobulin Production , 2002, Science.

[40]  J. Parrish-Novak,et al.  Interleukin‐21 and the IL‐21 receptor: novel effectors of NK and T cell responses , 2002, Journal of leukocyte biology.

[41]  M. Burdick,et al.  Interaction of IL-13 and C10 in the pathogenesis of bleomycin-induced pulmonary fibrosis. , 2002, American journal of respiratory cell and molecular biology.

[42]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[43]  R. Dutton,et al.  The Role of Adoptively Transferred CD8 T Cells and Host Cells in the Control of the Growth of the EG7 Thymoma: Factors That Determine the Relative Effectiveness and Homing Properties of Tc1 and Tc2 Effectors1 , 2001, The Journal of Immunology.

[44]  Scott R. Presnell,et al.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.

[45]  B. Antus,et al.  Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. , 2000, Cellular immunology.

[46]  R. Wise,et al.  Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. , 1999, Arthritis and rheumatism.

[47]  D. Cohen,et al.  T cell independence of bleomycin‐induced pulmonary fibrosis , 1999, Journal of leukocyte biology.

[48]  A. Cerwenka,et al.  Migration Kinetics and Final Destination of  Type 1 and Type 2 CD8 Effector Cells Predict Protection against Pulmonary Virus Infection , 1999, The Journal of experimental medicine.

[49]  T. Mosmann,et al.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. , 1995, Immunity.

[50]  M. Croft,et al.  Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles , 1994, The Journal of experimental medicine.

[51]  T. Mak,et al.  A role for CD4+ T cells in the pathogenesis of skin fibrosis in tight skin mice , 1994, European journal of immunology.

[52]  P. Vassalli,et al.  Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis , 1989, The Journal of experimental medicine.

[53]  R. Colvin,et al.  Usual interstitial pneumonitis is a T-cell alveolitis. , 1986, Clinical immunology and immunopathology.

[54]  T. Medsger,et al.  Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. , 2013, Arthritis and rheumatism.

[55]  R. Simms,et al.  The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes Different SSc Clinical Phenotypes , 2009 .

[56]  R. Puri,et al.  IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis , 2006, Nature Medicine.

[57]  T. Wynn.  Fibrotic disease and the T(H)1/T(H)2 paradigm. , 2004, Nature reviews. Immunology.

[58]  G. Izbicki,et al.  Lymphokines in bleomycin-induced lung injury in bleomycin-sensitive C57BL/6 and -resistant BALB/c mice. , 2000, Experimental lung research.